ACCORD Clinical Trial

ACCORD is a research program for people with Type 2 diabetes offering:

• Expert diabetes care and education.
• Study medications at no cost
• Opportunity to improve diabetes care for you and future
  generations.
  

The ACCORD trial is a multi-center trial funded by the National Heart and Lung Institute designed to determine if intensive glycemic control, treatment to increase HDL-cholesterol and lower triglycerides (in the context of good LDL-C and glycemia control), and intensive blood pressure control (in the context of good glycemia control) reduces cardiovascular events in patients with type 2 diabetes.

The University of Minnesota is one of the sites of this trial. Dr. Elizabeth Seaquist is the principal investigator at the University. More information about the trial can be obtained at www.accordtrial.org or by calling Mike Mech, Study Coordinator, at the University of Minnesota at 612/624-6101.